Bold Thinking that Delivers Results for RNA Therapies

Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.

While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approvedveristat therapeutic centers of excellence therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.

In this piece, learn how Veristat has supported some of our Biotech Sponsors in advancing their RNA therapeutics, including:
  • A landmark RNA approval
  • Navigating a full-service COVID-19 vaccine trial
  • Ensuring a Successful Regulatory Agency Interaction

DOWNLOAD NOW

 

Meet Veristat. Learn More.


 

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...

1 min read

Swiss Biotech Day

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

With nearly 30 years of experience in clinical trial...